Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer

NCT00499668 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped slow accrual

Conditions

Myeloproliferative Disorders
Leukemia
Lymphoma
Lymphoproliferative Disorder
Multiple Myeloma and Plasma Cell Neoplasm
Myelodysplastic Syndromes
Nausea and Vomiting
Solid Tumor

Interventions

DRUG: aprepitant
DRUG: ondansetron hydrochloride

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]